Literature DB >> 20931183

Primary angioplasty for a subtype of symptomatic middle cerebral artery stenosis.

Zhongrong Miao1, Bin Wang, Lei Feng, Yang Hua, Feng Ling.   

Abstract

INTRODUCTION: The purpose of this study was to assess the long-term efficacy of middle cerebral artery revascularisation by primary balloon angioplasty for the prevention of stroke in a certain subtype of patients.
METHOD: A retrospective study was performed to evaluate 33 patients with symptomatic middle cerebral artery stenoses who underwent primary balloon angioplasty; the selection criteria were: greater than 70% stenosis measured by digital subtraction angiography, lesions equal to or shorter than 5 mm, lesions near or across a bifurcation, and lesions with very tortuous proximal vessels that increase the risk of stenting. All patients were available for follow-up ranging from 6 to 60 months. The technical success rate, periprocedural complications, and long-term outcome were retrospectively reviewed. RESULT: The mean stenosis degree was reduced from 87.12 ± 7.40 to 23.03 ± 9.84 after angioplasty. The periprocedural complication rate was 18.18% (six dissections without an ischemic event). Two patients had strokes in the territory of the angioplasty at 6 and 32 months after angioplasty, and the stroke-free survival at 5 years was 90.04% (mean survival time, 56.42 ± 2.43 months; 95% CI, 51.66-61.19 months).
CONCLUSION: These results suggest that this treatment is safe and could provide a durable clinical result at long-term follow-up in this subtype of patients, but the high rate of dissection remains a major technical drawback.

Entities:  

Mesh:

Year:  2010        PMID: 20931183     DOI: 10.1007/s00234-010-0778-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  28 in total

1.  Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.

Authors:  Rishi Gupta; Firas Al-Ali; Ajith J Thomas; Michael B Horowitz; Thomas Barrow; Nirav A Vora; Ken Uchino; Maxim D Hammer; Lawerence R Wechsler; Tudor G Jovin
Journal:  Stroke       Date:  2006-09-07       Impact factor: 7.914

2.  Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.

Authors:  Adnan I Qureshi; Haitham M Hussein; Ahmed El-Gengaihy; Mohamed Abdelmoula; M Fareed K Suri
Journal:  Neurosurgery       Date:  2008-05       Impact factor: 4.654

3.  Race and sex differences in the distribution of cerebral atherosclerosis.

Authors:  R J Wityk; D Lehman; M Klag; J Coresh; H Ahn; B Litt
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

4.  Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.

Authors:  V N Thijs; G W Albers
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

5.  Would self-expanding stent occlude middle cerebral artery perforators?

Authors:  Thomas W Leung; Simon C H Yu; Wynnie W M Lam; Anne Y Y Chan; Alexander Y L Lau; Lawrence K S Wong
Journal:  Stroke       Date:  2009-01-29       Impact factor: 7.914

6.  Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center.

Authors:  Zhongrong R Miao; Lei Feng; Shengmao Li; Fengshui Zhu; Xunming Ji; Liqun Jiao; Feng Ling
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

8.  Angioplasty for symptomatic intracranial stenosis: clinical outcome.

Authors:  Michael P Marks; Joan C Wojak; Firas Al-Ali; Mahesh Jayaraman; Mary L Marcellus; John J Connors; Huy M Do
Journal:  Stroke       Date:  2006-02-23       Impact factor: 7.914

Review 9.  Endovascular treatment of cerebrovascular diseases and intracranial neoplasms.

Authors:  Adnan I Qureshi
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Elective stenting of symptomatic middle cerebral artery stenosis.

Authors:  C R Gomez; V K Misra; M S Campbell; R D Soto
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  4 in total

1.  Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS.

Authors:  Zhongrong Miao; Ligang Song; David S Liebeskind; Liping Liu; Ning Ma; Yilong Wang; Dapeng Mo; Feng Gao; Xingquan Zhao; Kehui Dong; Dong Zhang; Peiyi Gao
Journal:  J Neurointerv Surg       Date:  2014-04-23       Impact factor: 5.836

2.  Safety and Efficacy Analyses of Angioplasty and Stenting for Severe Intracranial Arterial Stenosis: A Single-Center Retrospective Study in China.

Authors:  Rong Yin; Fei Chang; Bo Hong; Xiang-Qun Shi; Guo-Zhen Zhang; Zhao Liu; Zhi-Qiang Zhang; Ya-Xuan Wei; Jian-Min Liu
Journal:  Med Sci Monit       Date:  2015-10-31

3.  Intracranial artery stenosis: Current status of evaluation and treatment in China.

Authors:  Bin Cai; Bin Peng
Journal:  Chronic Dis Transl Med       Date:  2017-11-14

Review 4.  Intracranial Angioplasty and Stenting before and after SAMMPRIS: "From Simple to Complex Strategy - The Chinese Experience".

Authors:  Zhongrong Miao
Journal:  Front Neurol       Date:  2014-07-14       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.